Short Exposure to Moderate Concentration of Alcohol During Embryonic Development Does Not Alter Gross Morphology in Zebrafish

Ethyl glucuronide and ethyl sulfate in the zebrafish after ethanol exposure

Ethanol exposure during pregnancy is an important problem and is the cause of fetal alcohol syndrome (FAS) and fetal alcohol spectrum disorder (FASD). The etiology of FAS and FASD can be elucidated using animal models. Recently, a novel model, the zebrafish (Danio rerio), has garnered the interest of researchers. This study confirmed the negative influence of ethyl alcohol (0.5 %, 1.5 %, and 2.5 % v/v) on the development of zebrafish embryos. The observed malformations included pericardial and yolk sac edema, increased body curvature, tail edema, and a decreased embryo hatching rate. The differences in body length, body width, and heart rate were statistically significant. Due to the similarities in the quantity and function of ethanol biotransformation enzymes between zebrafish and mammals, this study investigated the nonoxidative metabolites of ethanol - ethyl glucuronide (EtG) and ethyl sulfate (EtS) - in zebrafish following ethanol exposure. This research confirmed that EtG and EtS concentrations can be measured in zebrafish embryos, and the levels of these metabolites appear to be associated with the ethyl alcohol concentration in the medium.

Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease

Neurological diseases, including neurodegenerative and neurodevelopmental disorders, affect nearly one in six of the world's population. The burden of the resulting deaths and disability is set to rise during the next few decades as a consequence of an aging population. To address this, zebrafish have become increasingly prominent as a model for studying human neurological diseases and exploring potential therapies. Zebrafish offer numerous benefits, such as genetic homology and brain similarities, complementing traditional mammalian models and serving as a valuable tool for genetic screening and drug discovery. In this comprehensive review, we highlight various drug delivery techniques and systems employed for therapeutic interventions of neurological diseases in zebrafish, and evaluate their suitability. We also discuss the challenges encountered during this process and present potential advancements in innovative techniques.

Long-term behavioral alterations following embryonic alcohol exposure in three zebrafish populations

Fetal alcohol exposure may lead to a condition known as fetal alcohol spectrum disorder (FASD), which comprises a set of consequences, including cognitive and behavioral impairments. Although zebrafish has been applied as a reliable model for studying FASD, there is no approach to the disorder's ontogeny and population differences. Here, we evaluated the behavioral outcomes of AB, Outbred (OB), and Tübingen (TU) zebrafish populations embryonically exposed to alcohol throughout the development to the adult stage. We exposed 24hpf eggs to 0%, 0.5%, or 1.0% alcohol for 2h. Fish were let grow and locomotor and anxiety-like behaviors were tested in a novel tank at larval - 6dpf, juvenile - 45dpf, and adult- 90dpf stages. At 6dpf, both AB and OB treated with 1.0% alcohol showed hyperactivity, while 0.5% and 1.0% TU fish exhibited hypolocomotion. At 45dpf, AB and TU fish maintained the larval pattern of locomotion. At the adult stage - 90dpf, both AB and TU populations showed increased locomotor activity and anxiogenic responses, while the OB population did not show altered behavior. Our results show for the first time that zebrafish populations exhibit behavioral differences in response to embryonic alcohol exposure and that it varies along animals' ontogeny. AB fish showed the most consistent behavioral pattern through developmental stages, TU fish showed behavioral changes only in adulthood, and OB population showed high interindividual variability. These data reinforce that different populations of zebrafish are better adapted to translational studies, offering reliable results in contrast to domesticated OB populations obtained from farms, which exhibit more variable genomes.

Lasting effects of mild embryonic ethanol exposure on voltage-gated ion channels in adult zebrafish brain

The zebrafish is increasingly well utilized in alcohol research, particularly in modeling human fetal alcohol spectrum disorders (FASD). FASD results from alcohol reaching the developing fetus intra utero, a completely preventable yet prevalent and devastating life-long disorder. The hope with animal models, including the zebrafish, is to discover the mechanisms underlying this disease, which may aid treatment and diagnosis. In the past, we developed an embryonic alcohol exposure regimen that is aimed at mimicking the milder, and most prevalent, forms of FASD in zebrafish. We have found numerous lasting alterations in behavior, neurochemistry, neuronal markers and glial cell phenotypes in this zebrafish FASD model. Using the same model (2 h long bath immersion of 24 h post-fertilization old zebrafish eggs into 1% vol/vol ethanol), here we conduct a proof of concept analysis of voltage-gated cation channels, investigating potential embryonic alcohol induced changes in L-, T- and N- type Ca⁺⁺ and the SCN1A Na⁺ channels using Western blot followed by immunohistochemical analysis of the same channels in the pallium and cerebellum of the zebrafish brain. We report significant reduction of expression in all four channel proteins using both methods. We conclude that reduced voltage-gated cation channel expression induced by short and low dose exposure to alcohol during embryonic development of zebrafish may contribute to the previously demonstrated lasting behavioral and neurobiological changes.